A

Axiom Bio

AI-driven hepatotoxicity prediction for drugs

Scientist – Drug Discovery

Translational Research & Bench BiologyUpdated on Nov 13
Full-timeSouth San Francisco, CA, USANo salary listedIn-person

About the Job

Requirements

  • A track record of advancing drug discovery programs through hit-to-lead, lead optimization, or candidate nomination, with direct responsibility for consequential scientific decisions.
  • Strong medicinal chemistry judgment, including interpreting structure–activity and structure–property relationships, designing informative compound series, and balancing competing objectives.
  • Fluency in ADME/DMPK, PK/PD, and exposure–response relationships, with the ability to connect experimental measurements to the profile needed for a successful drug.
  • Ability to integrate chemistry, biology, toxicology, and computational evidence into clear hypotheses, decisive experiments, and well-supported go/no-go recommendations.
  • Experience building or using scientific AI agents, with the curiosity to rethink discovery workflows and the judgment to verify outputs against experimental evidence.
  • Ability to turn an ambitious program goal into an experimental and analytical plan, coordinate execution, and adapt quickly as results arrive.
  • Strong scientific communication and the ability to earn the trust of biotech and pharmaceutical partners, understand their priorities, and translate findings into program decisions.
  • Knowledge of medicinal chemistry, compound design, SAR analysis, matched molecular pairs, and multi-parameter optimization.
  • Knowledge of ADME/DMPK, PK/PD, exposure–response analysis, human dose projection, and safety margin assessment.
  • Knowledge of mechanistic toxicology, drug metabolism, reactive metabolites, and interpretation of human cell-based assays.
  • Familiarity with scientific AI agents for literature and patent research, data analysis, hypothesis generation, molecular design, and experimental planning.
  • Proficiency in Python, RDKit, NumPy, pandas, SQL, and reproducible analytical workflows.
  • Knowledge of experimental design, dose–response modeling, statistical analysis, assay validation, and integration of imaging, transcriptomic, and biochemical data.
  • Ability to prepare clear scientific presentations, program reviews, and evidence packages that support partner decisions and licensing discussions.

Responsibilities

  • Lead drug discovery programs from initial hypothesis through lead optimization, integrating medicinal chemistry, human biology, computational methods, and AI agents to develop safer, more effective drugs.
  • Help select programs where the company has a distinctive advantage, define target product and compound profiles, and establish clear milestones and go/no-go criteria.
  • Own the design–make–test–analyze cycle, working with computational scientists, experimental teams, and synthesis partners to design molecules, prioritize experiments, interpret results, and decide next steps.
  • Use and help develop scientific agents that investigate toxicity mechanisms, integrate evidence, propose chemical modifications, and guide experimental decisions.
  • Own scientific relationships and deliverables for biotech and pharmaceutical partners, translating program goals into experimental plans, rigorous analyses, and actionable recommendations.
  • Ensure the quality and reproducibility of program data, distinguish meaningful findings from artifacts, and test whether improvements in potency, safety, and exposure support the intended drug profile.
  • Work with scientific and commercial leadership to build evidence packages for partnerships and licensing opportunities before clinical development.
  • Turn insights from internal programs and customer engagements into reusable tools, analyses, and agent workflows.
  • Partner with machine learning researchers and AI labs to turn experimental campaigns into benchmarks and reinforcement learning environments that improve models’ scientific judgment and molecular design.

About the Company

Axiom Bio

AI-driven hepatotoxicity prediction for drugs

Axiom Bio provides an AI-driven platform for predictive toxicology that helps drug researchers identify potential liver toxicity early in development. The platform uses a large proprietary dataset—over 115,000 small molecules screened on primary human liver cells with imaging and biochemical readouts, plus PK and clinical data—to predict drug-induced liver injury and related toxicity pathways from a molecule’s structure. It differentiates itself through its large human-toxicity dataset and by offering mechanistic insights (such as mitochondrial toxicity, ER stress, and ROS) at a low per-molecule cost. The goal is to speed up safe drug development by de-risking preclinical pipelines and reducing reliance on animal testing.

Company size
11-50
Company stage
Seed
Total funding
$15M
Headquarters
San Francisco, CA
Founded
2024

Recently Posted Jobs

Explore more opportunities at Axiom Bio

See more jobs